![John Brancaccio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Brancaccio
Directeur/Membre du Conseil chez
TIZIANA LIFE SCIENCES LTD
Fortune : 45 302 $ au 30/06/2026
Profil
John Patrick Brancaccio currently works at OKYO Pharma Ltd., as Independent Non-Executive Director from 2020, FermaVir Pharmaceuticals LLC, as Director from 2005, Actavia Life Sciences, Inc., as Independent Director from 2016, AccuStem Sciences, Inc., as Independent Non-Executive Director from 2021, Tiziana Life Sciences Ltd., as Independent Non-Executive Director from 2020, and Tiziana Life Sciences Ltd. (United Kingdom), as Non-Executive Director.
Mr. Brancaccio also formerly worked at Hepion Pharmaceuticals, Inc., as Chairman & Chief Financial Officer in 2025, Callisto Pharmaceuticals, Inc., as Independent Director from 2004 to 2013, Pawfect Foods, Inc., as Director, Active With Me, Inc., as Director, Cardiff Oncology, Inc., as Independent Director from 2005 to 2022, Synergy Pharmaceuticals LLC, as Independent Director from 2008 to 2019, Tamir Biotechnology, Inc., as Director from 2004 to 2019, Rasna Therapeutics, Inc., as Director in 2016, Eline Entertainment Group, Inc., as Chief Financial & Operating Officer from 2000 to 2002, Memory Pharmaceuticals Corp., as Chief Financial Officer, Secretary & Treasurer from 2002 to 2004, Orchestra Medical Ventures LLC, as Chief Financial Officer, and Accelerated Technologies, Inc., as Chief Financial Officer from 2004 to 2017.
Mr. Brancaccio received his undergraduate degree from Seton Hall University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OKYO PHARMA LIMITED 0,06 % | 08/06/2026 | 30 201 ( 0,06 % ) | 45 302 $ | 30/06/2026 |
| 03/07/2018 | 3 ( 0,16 % ) | 0 $ | 30/06/2026 | |
| 31/12/2024 | 0 ( -.--% ) | - $ | 30/06/2026 | |
| 31/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de John Brancaccio
| Sociétés | Poste | Début |
|---|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Directeur/Membre du Conseil | 01/08/2016 |
| WEST AFRICAN MINERALS CORP | Directeur/Membre du Conseil | 10/06/2020 |
| ACCM SCIE | Directeur/Membre du Conseil | 01/03/2021 |
| TIZIANA LIFE SCIENCES LTD | Directeur/Membre du Conseil | 01/07/2020 |
FermaVir Pharmaceuticals LLC
 FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur/Membre du Conseil | 24/09/2005 |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Directeur/Membre du Conseil | - |
Anciens postes connus de John Brancaccio
| Sociétés | Poste | Fin |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Directeur Général | 16/06/2025 |
| CARDIFF ONCOLOGY, INC. | Directeur/Membre du Conseil | 09/06/2022 |
| SYNERGY PHARMACEUTICALS INC | Directeur/Membre du Conseil | 01/04/2019 |
| ░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de John Brancaccio
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
50
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Engages in discovering and developing new class of therapeutic drugs | Health Technology |
Eline Entertainment Group, Inc.
 Eline Entertainment Group, Inc. Movies/EntertainmentConsumer Services Provides sports and entertainment production and distribution services | Consumer Services |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops novel therapeutics to treat cancer | Health Technology |
Pawfect Foods, Inc.
 Pawfect Foods, Inc. Specialty StoresRetail Trade Sells pet food via the internet | Retail Trade |
OKYO Pharma Ltd.
 OKYO Pharma Ltd. BiotechnologyHealth Technology Develops next-generation therapeutics to improve the lives of patients suffering from inflammatory eye diseases | Health Technology |
Hepion Pharmaceuticals, Inc.
 Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Active With Me, Inc.
 Active With Me, Inc. Miscellaneous Commercial ServicesCommercial Services Provides online resources that seamlessly offer travelers unique, relevant and user-friendly information on activity-based travel | Commercial Services |
Memory Pharmaceuticals Corp.
 Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Cardiff Oncology, Inc.
 Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
Seton Hall University
 Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orchestra Medical Ventures LLC
 Orchestra Medical Ventures LLC Investment ManagersFinance Orchestra Medical Ventures seeks investment opportunities in companies located in the United States. The firm focuses on companies operating in the fields of medical technology. It provides financing for early stage capital requirements. | Finance |
FermaVir Pharmaceuticals LLC
FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Accelerated Technologies, Inc.
 Accelerated Technologies, Inc. Medical DistributorsDistribution Services Creates and accelerates cardiovascular medical device | Distribution Services |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases | Health Technology |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Health Technology |
Rasna Therapeutics, Inc. /Old/
 Rasna Therapeutics, Inc. /Old/ Medical DistributorsDistribution Services Develops cancer drugs | Distribution Services |
Actavia Life Sciences, Inc.
 Actavia Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
AccuStem Sciences, Inc.
 AccuStem Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomics-based personalized medicines for breast cancer patients | Health Technology |
Tiziana Life Sciences Ltd.
 Tiziana Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Choisissez Zonebourse 
